The 20 Best Omenn Syndrome Doctors Near Me in District of Columbia, US

Michael Keller, MD, is a pediatric immunologist, the director of the Translational Research Laboratory in the Cellular Therapy Program and associate professor of Pediatrics at Children’s National Hospital and George Washington University. He specializes in the diagnosis and treatment of primary and secondary immunodeficiency disorders. Dr. Keller’s research interests are in the application of cellular therapies to treat and prevent viral illnesses in immunocompromised patients, including children with inborn errors of immunity and patients undergoing bone marrow transplantation. He has led 10 investigator-initiated trials of virus-specific T cell therapy on which over 180 patients have been treated over the past decade, including national consortium studies. He is also co-lead of the joint NIAID-Children’s National clinical immunology research program (with Dr. Luigi Notarangelo) and has contributed to the descriptions of many new inborn errors of immunity. Dr. Keller has served on multiple national committees, including as chair of the Primary Immunodeficiency Committee for the American Academy of Asthma, Allergy and Immunology (2018-2022) and vice-chair of the Cellular Therapy Committee for the Pediatric Transplantation and Cellular Therapy Consortium (2022-present). He also serves as an author and section editor for multiple topics on inborn errors of immunity on uptodate.com. Dr. Keller lives in Maryland with his wife and two sons, and enjoys travel, hiking and martial arts. Publications ORCiD. Dr. Keller is rated as an Experienced provider by MediFind in the treatment of Omenn Syndrome. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Primary Immunodeficiency (PID), Asthma, Common Variable Immune Deficiency, and Wiskott-Aldrich Syndrome. Dr. Keller is board certified in Allergy And Immunology: American Board Of Allergy And Immunology, 2012 and Pediatrics: American Board Of Pediatrics, 2010.

David Jacobsohn, MD, ScM, MBA, is the division chief of the Blood and Marrow Transplantation Program at Children’s National Hospital and full professor of Pediatrics at the George Washington University. He leads a program of upwards of 70 pediatric transplants per year. The program performs transplants in patients with malignant and non-malignant conditions, and has expertise with all stem cell sources including haplo-identical transplants. His expertise is in graft-versus-host disease (GvHD) clinical trials: reducing incidence of GvHD as well as novel therapies for GvHD. He has more than 10 years of experience in clinical research in pediatric GvHD. His work has included the study of novel drugs for chronic GvHD, classification criteria for chronic GvHD, and risk factor stratification in pediatric chronic GvHD. He is active in the BMT community at a national level. Examples of some current and prior roles include head of the GVHD committee for the Pediatric Blood and Marrow Transplant Consortium, member-at-large of the that Consortium, member of the Children’s Oncology Group Stem Cell Transplant Committee, member of the Clinical Trials Network State of the Science Pediatric Advisory Group. Dr. Jacobsohn has been instrumental in growing the capabilities of the Blood and Marrow Transplant Program. For example, for the last five years the program is one of the few pediatric programs performing alpha/beta T cell depletion for haploidentical transplants. This novel method for GVHD prevention has significantly improved the outcome of haploidentical BMT at Children’s National. Additionally, he has been involved with the deployment of gene therapy for hemoglobinopathies. He successfully led Children’s National to become the first program in the country to collect stem cells for a commercial sickle cell gene therapy treatment. Dr. Jacobsohn is rated as an Experienced provider by MediFind in the treatment of Omenn Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Hemoglobinopathy, Anemia, Sickle Cell Disease, and Bone Marrow Transplant. Dr. Jacobsohn is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2002 and Pediatrics: American Board Of Pediatrics, 1999.

Blachy Davila is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Davila is rated as an Experienced provider by MediFind in the treatment of Omenn Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Hemophagocytic Lymphohistiocytosis, Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.

Asma Dilawari is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Dilawari is rated as an Experienced provider by MediFind in the treatment of Omenn Syndrome. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Dan Brody is an Allergy and Immunologist practicing medicine in Washington, Washington, D.c.. Dr. Brody is rated as an Experienced provider by MediFind in the treatment of Omenn Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Asthma, Sinusitis, Grass Allergy, and Allergic Rhinitis.